Amgen Inc (LTS:0R0T)
$ 269.5 0 (0%) Market Cap: 160.64 Bil Enterprise Value: 212.02 Bil PE Ratio: 38.26 PB Ratio: 21.34 GF Score: 91/100

Amgen Inc at Cowen Healthcare Conference (Virtual) Transcript

Mar 04, 2021 / 05:50PM GMT
Release Date Price: $226.98 (+1.29%)
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

Good afternoon, everybody, and thank you once again for the final day of the 41st Annual Cowen Healthcare Conference. I'm Yaron Werber from the biotech team. And it's a pleasure to moderate the fireside chat with Amgen, with my colleague, Gabe Schneider. And we are very pleased to have the full team here today. We have Peter Griffith, who's EVP and CFO; Murdo Gordon, EVP, Global Commercial Ops; and David Reese, EVP of R&D; and Arvind Sood, of course, our VP of Investor Relations.

Gentlemen, thank you so much for joining us. We appreciate it. And we have a box open on the screen. If anybody has questions, you can pop them in there and we'll do our best to ask them on your behalf or you can e-mail us directly, and we'll be happy to take them.

So Peter, maybe let me turn it over to you maybe for some introductory remarks about how the business is going, and then we'll dive into Q&A.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot